Cabral-Miranda, G., Heath, M. D., Mohsen, M. O., Gomes, A. C., Engeroff, P., Flaxman, A., . . . Bachmann, M. F. (2017). Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax. MDPI AG.
Chicago Style (17th ed.) CitationCabral-Miranda, Gustavo, et al. Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection Against Plasmodium Berghei/vivax. MDPI AG, 2017.
MLA引文Cabral-Miranda, Gustavo, et al. Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection Against Plasmodium Berghei/vivax. MDPI AG, 2017.